• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光学相干断层成像评估的组织特征与紫杉醇涂层球囊扩张治疗支架内再狭窄病变的中期结果的关系:与普通球囊血管成形术的比较。

Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.

机构信息

Department of Cardiovascular Medicine, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki 710-8602, Japan.

出版信息

Eur Heart J Cardiovasc Imaging. 2014 Mar;15(3):307-15. doi: 10.1093/ehjci/jet165. Epub 2013 Sep 15.

DOI:10.1093/ehjci/jet165
PMID:24042176
Abstract

AIMS

Morphological assessment of neointimal tissue using optical coherence tomography (OCT) is important for clarifying the pathophysiology of in-stent restenosis (ISR) lesions. The aim of this study was to determine the impact of OCT findings on recurrence of ISR after paclitaxel-coated balloon (PCB) dilatation compared with plain old balloon angioplasty (POBA).

METHODS AND RESULTS

Between July 2008 and May 2012, we performed percutaneous coronary intervention for 214 ISR lesions using POBA + PCB (146 lesions, PCB group) or POBA only (68 lesions, POBA group). Morphological assessment of neointimal tissue using OCT, including assessment of restenotic tissue structure and restenotic tissue backscatter, was performed. We examined the association between lesion morphologies and mid-term (6-8 months) results including ISR and target lesion revascularization (TLR) rates. Both ISR and TLR rates of lesions with a homogeneous structure were significantly lower in the PCB group than those in the POBA group (ISR: 20.0 vs. 55.6%, P = 0.002, TLR: 12.7 vs. 37.0%, P = 0.019), but there was no difference between the two groups in ISR and TLR rates of lesions with a heterogeneous or layered structure. Both ISR and TLR rates of lesions with high backscatter were significantly lower in the PCB group than those in the POBA group (ISR: 19.8 vs. 52.5%, P < 0.001, TLR: 13.6 vs. 42.5%, P = 0.001), but there was no difference between the two groups in ISR and TLR rates of lesions with low backscatter.

CONCLUSION

Morphological assessment of ISR tissue using OCT might be useful for identifying ISR lesions favourable for PCB dilatation.

摘要

目的

光学相干断层扫描(OCT)对新生内膜组织的形态评估对于阐明支架内再狭窄(ISR)病变的病理生理学机制非常重要。本研究旨在比较紫杉醇涂层球囊(PCB)扩张与普通球囊血管成形术(POBA)治疗后 OCT 发现对 ISR 复发的影响。

方法和结果

2008 年 7 月至 2012 年 5 月,我们对 214 例 ISR 病变采用 POBA+PCB(146 例,PCB 组)或仅 POBA(68 例,POBA 组)进行经皮冠状动脉介入治疗。采用 OCT 对新生内膜组织进行形态评估,包括评估再狭窄组织的结构和再狭窄组织的后散射。我们研究了病变形态与中期(6-8 个月)结果之间的关系,包括 ISR 和靶病变血运重建(TLR)的发生率。在 PCB 组,结构均匀的病变的 ISR 和 TLR 发生率显著低于 POBA 组(ISR:20.0%比 55.6%,P=0.002;TLR:12.7%比 37.0%,P=0.019),但结构不均匀或分层的病变两组间 ISR 和 TLR 发生率无差异。在 PCB 组,后散射高的病变的 ISR 和 TLR 发生率显著低于 POBA 组(ISR:19.8%比 52.5%,P<0.001;TLR:13.6%比 42.5%,P=0.001),但后散射低的病变两组间 ISR 和 TLR 发生率无差异。

结论

OCT 对 ISR 组织的形态评估可能有助于识别有利于 PCB 扩张的 ISR 病变。

相似文献

1
Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.光学相干断层成像评估的组织特征与紫杉醇涂层球囊扩张治疗支架内再狭窄病变的中期结果的关系:与普通球囊血管成形术的比较。
Eur Heart J Cardiovasc Imaging. 2014 Mar;15(3):307-15. doi: 10.1093/ehjci/jet165. Epub 2013 Sep 15.
2
Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.光学相干断层扫描评估的组织特征与经皮冠状动脉介入治疗支架内再狭窄病变的中期结果之间的关联:球囊血管成形术、紫杉醇涂层球囊扩张术和药物洗脱支架植入术的比较
Eur Heart J Cardiovasc Imaging. 2015 Oct;16(10):1101-11. doi: 10.1093/ehjci/jev031. Epub 2015 Mar 9.
3
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).紫杉醇涂层球囊与球囊血管成形术治疗的长期结果:PEPCAD-DES 研究的见解(使用 SeQuent Please 紫杉醇涂层经皮腔内冠状动脉血管成形术 [PTCA] 导管治疗药物洗脱支架 [DES] 支架内再狭窄)。
JACC Cardiovasc Interv. 2015 Nov;8(13):1695-700. doi: 10.1016/j.jcin.2015.07.023.
4
Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.药物涂层球囊与球囊血管成形术治疗后药物洗脱支架再狭窄的血管造影模式:PEPCAD-DES研究的晚期管腔丢失亚组分析
Catheter Cardiovasc Interv. 2016 Oct;88(4):529-534. doi: 10.1002/ccd.26451. Epub 2016 Feb 19.
5
Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.准分子激光与切割球囊血管成形术治疗局灶性支架内再狭窄病变的光学相干断层扫描结果及临床结局差异。
J Invasive Cardiol. 2012 Oct;24(10):478-83.
6
Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.药物洗脱支架内再狭窄的单纯球囊扩张术:光学相干断层扫描分析
Cardiovasc Revasc Med. 2015 Jan-Feb;16(1):27-31. doi: 10.1016/j.carrev.2014.11.002. Epub 2014 Nov 20.
7
Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.雷帕霉素洗脱支架和球囊血管成形术治疗雷帕霉素洗脱支架内再狭窄的安全性和有效性。
Cardiovasc Revasc Med. 2015 Mar;16(2):84-9. doi: 10.1016/j.carrev.2015.01.004. Epub 2015 Jan 29.
8
Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.紫杉醇涂层球囊血管成形术后晚期再狭窄发生于药物洗脱支架再狭窄患者中。
J Am Coll Cardiol. 2015 Jul 7;66(1):14-22. doi: 10.1016/j.jacc.2015.05.002.
9
A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.紫杉醇涂层球囊导管与常规球囊血管成形术治疗金属裸支架再狭窄和药物洗脱支架再狭窄患者的多中心随机比较。
Am Heart J. 2013 Sep;166(3):527-33. doi: 10.1016/j.ahj.2013.07.002. Epub 2013 Aug 13.
10
Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.紫杉醇涂层球囊血管成形术治疗药物洗脱支架再狭窄后再狭窄的光学相干断层成像预测因子。
Circ J. 2018 Oct 25;82(11):2820-2828. doi: 10.1253/circj.CJ-18-0464. Epub 2018 Aug 30.

引用本文的文献

1
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-Eluting Stent Implantation or Drug-Coated Balloon Angioplasty According to Neointima Morphology in Drug-Eluting Stent REstenosis 5: Rationale and Design of the ISAR-DESIRE 5 Trial.冠状动脉内支架置入与再狭窄——药物洗脱支架再狭窄5中根据新生内膜形态进行药物洗脱支架植入或药物涂层球囊血管成形术的随机试验:ISAR-DESIRE 5试验的原理与设计
J Cardiovasc Transl Res. 2025 Jun 30. doi: 10.1007/s12265-025-10650-x.
2
Serial Change and Clinical Impact of Irregular Protrusion in Lesions With Chronic Coronary Syndrome.慢性冠状动脉综合征病变中不规则突出的连续变化及临床影响
Catheter Cardiovasc Interv. 2025 Apr;105(5):1149-1160. doi: 10.1002/ccd.31430. Epub 2025 Feb 3.
3
Widespread Use of Imaging-Guided PCI in Asia: Time for Extended Application.
亚洲成像引导下经皮冠状动脉介入治疗的广泛应用:是时候扩大应用范围了。
JACC Asia. 2024 Aug 20;4(9):639-656. doi: 10.1016/j.jacasi.2024.07.003. eCollection 2024 Sep.
4
Endovascular Drug Delivery.血管内药物递送
Life (Basel). 2024 Mar 28;14(4):451. doi: 10.3390/life14040451.
5
Intravascular Imaging for Guiding In-Stent Restenosis and Stent Thrombosis Therapy.血管内影像学在指导支架内再狭窄和支架内血栓形成治疗中的应用。
J Am Heart Assoc. 2022 Nov 15;11(22):e026492. doi: 10.1161/JAHA.122.026492. Epub 2022 Nov 3.
6
Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.血管病变特异性药物输送系统:JACC 最新综述。
J Am Coll Cardiol. 2021 May 18;77(19):2413-2431. doi: 10.1016/j.jacc.2021.03.307.
7
Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis.冠状动脉支架内再狭窄患者的新生内膜光学特征与治疗方式的临床结果。
EuroIntervention. 2021 Aug 6;17(5):e388-e395. doi: 10.4244/EIJ-D-20-00662.
8
Effect of drug-coated balloon angioplasty on in-stent restenotic coronary lesions analyzed with optical coherence tomography and serial coronary artery angioscopy.药物涂层球囊血管成形术对支架内再狭窄冠状动脉病变的影响:光学相干断层扫描和系列冠状动脉血管内镜分析
Heart Vessels. 2019 Dec;34(12):1925-1935. doi: 10.1007/s00380-019-01447-5. Epub 2019 Jun 15.
9
In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.使用频域光学相干断层扫描评估的支架内再狭窄显示第二代药物洗脱支架中冠状动脉愈合过程顺利。
Singapore Med J. 2019 Jan;60(1):48-51. doi: 10.11622/smedj.2018038. Epub 2018 Apr 10.
10
Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.两种不同涂层的紫杉醇药物洗脱球囊治疗支架内再狭窄的抗再狭窄疗效的比较评估
Clin Res Cardiol. 2016 May;105(5):401-11. doi: 10.1007/s00392-015-0934-0. Epub 2015 Nov 5.